Galderma is pleased to announce the grand opening of its U.S. headquarters in downtown Dallas. Galderma relocated its nearly 300 home office employees to the Trammell Crow Center at 2001 Ross Avenue. The grand opening event on Friday, December 9, was celebrated with Dallas Mayor Eric Johnson, Galderma Chief Executive Officer Flemming Ørnskov, M.D., MPH, representatives from Downtown Dallas Initiative and Galderma associates. 

With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the pure-play dermatology category leader. Spanning the full spectrum of the fast-growing dermatology market, Galderma offers a synergistic portfolio of premium flagship brands with leading market positions in their respective product categories, supported by science-based product differentiation and premium positioning. In Dermo-cosmetics, Galderma’s portfolio includes dermatologist-recommended Cetaphil moisturizing and cleansing products for sensitive skin; the physician-dispensed Alastin product line; and Differin, the first FDA-approved, prescription-strength, retinoid acne treatment available without a prescription. Its Injectable Aesthetics portfolio includes a diverse range of hyaluronic fillers, as well as a biostimulator and a neuromodulator. Galderma’s Therapeutic Dermatology products include physician-prescribed FDA-approved products for acne and rosacea. Galderma’s range of anti-acne products is the No.1 choice globally¹.

“We are thrilled to welcome Galderma, a global dermatology leader, to our city," Dallas Mayor Eric Johnson said. "Galderma’s decision to relocate to Dallas showcases our city's strength in the biotech industry and our reputation as a business-friendly community where opportunities abound. We know that our new friends from Galderma will enjoy their new home at the Trammell Crow Center and that their workers will love all the vibrancy, fun, and excitement that Downtown Dallas has to offer.”

The state-of-the-art office space at the Trammell Crow Center features 50,000 square feet on the 16^th and 17^th floors and offers stunning views of downtown and the Dallas Arts District. Its interior is modern and open and was designed to promote collaboration, creativity, productivity and connections. To promote comfort and wellbeing, the new offices feature adjustable desks for both sitting and standing, a private nursing room for new mothers, and several lounge areas with soft seating and large meeting spaces for company events and celebrations.

“We wanted to create a work environment that energizes employees and teams and allows for easy engagement between people. I believe the new space here in the Trammell Crow Center does exactly that,” said Silvina Nordenstohl, Head of Galderma U.S. “Our flagship brand Cetaphil was discovered in the state of Texas back in 1947. Having our U.S. headquarters here in Dallas allows us to maintain our Texas roots as we open a new era for Galderma in a premium location with access to top talent. We have found the perfect home in Dallas.”

Media Contact:

Zach Randles-Friedman

Head of Communications

+1 305 299 5700

Zach.Randles-Friedman@galderma.com 

ABOUT GALDERMA

Galderma is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that spans the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermo-cosmetics and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we’re in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com/us.

1- Based on internal analysis by Galderma using data from the following source: IQVIA: MIDAS® Global Quarterly, Q2 2022, ATC: D10 ANTI-ACNE PREPARATIONS, 75 countries, for the time period MAT Q2 2022 reflecting estimates of real-world activity. Copyright IQVIA. All rights reserved.